Explainable AI-driven precision clinical trial enrichment: demonstration of the NetraAI platform with a phase II depression trial - Summary - MDSpire

Explainable AI-driven precision clinical trial enrichment: demonstration of the NetraAI platform with a phase II depression trial

  • By

  • Joseph Geraci

  • Bessi Qorri

  • Mike Tsay

  • Christian Cumbaa

  • Paul Leonczyk

  • Larry Alphs

  • Elizabeth D. Ballard

  • Carlos A. Zarate

  • Luca Pani

  • December 8, 2025

  • 0 min

Share

Objective:

Emphasize the significance of addressing clinical trial failures due to patient heterogeneity.

Key Findings:
  • Include implications of findings for clinical practice.
Interpretation:

Compare NetraAI's approach to traditional methods for clarity.

Limitations:
  • Suggest potential solutions or future research directions to address limitations.
Conclusion:

Reinforce the broader transformative potential of NetraAI beyond the specific study context.

Original Source(s)

Explainable AI-driven precision clinical trial enrichment: demonstration of the NetraAI platform with a phase II depression trial

  • by Joseph Geraci, Bessi Qorri, Mike Tsay, Christian Cumbaa, Paul Leonczyk, Larry Alphs, Elizabeth D. Ballard, Carlos A. Zarate, Luca Pani

  • December 8, 2025

Related Content

Digital mental health interventions in Chinese: a scoping review

Strategies for Safeguarding Refugee Children Against Mental Health Issues: A Scoping Review of Alterable Factors for Preventive Measures

The Dual-Burden of Professional and Academic Stress: A Cross-Sectional Mapping of Mental Health Status and Coping Efficacy Among Postgraduate Students in Nairobi, Kenya